Skip to main content

Advertisement

SpringerLink
Log in

The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group

  • Epidemiology of Fungal Infections (T Chiller and J Baddley, Section Editors)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019.

Recent Findings

Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and symptoms of this disease are often non-specific, making it difficult to establish a diagnosis. Although with the recent technological advances, in vitro diagnostics and medicines for histoplasmosis are often not available in many regions around the world. In addition, histoplasmosis is often not included in HIV care and treatment programs, resulting in inadequate health system planning and missed opportunities to save lives.

Summary

The II Regional Meeting on Histoplasmosis in the Americas gathered a multidisciplinary audience. Developed recommendations to be included in the WHO guidelines for diagnosis and treatment of histoplasmosis in advanced HIV were the product of this meeting, and guidelines are aimed to be published in early 2020.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Adenis AA, Aznar C, Couppie P. Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps. Current tropical medicine reports. 2014;1:119–28. https://doi.org/10.1007/s40475-014-0017-8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol. 2017;55(6):1612–20. https://doi.org/10.1128/JCM.02430-16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gomez BL. Molecular diagnosis of endemic and invasive mycoses: advances and challenges. Rev Iberoam Micol. 2014;31(1):35–41. https://doi.org/10.1016/j.riam.2013.09.009.

    Article  PubMed  Google Scholar 

  4. •• Caceres DH, Knuth M, Derado G, Lindsley MD. Diagnosis of progressive disseminated histoplasmosis in advanced HIV: a meta-analysis of assay analytical performance. J Fungi (Basel). 2019;5(3). https://doi.org/10.3390/jof5030076Systematic review and meta-analysis on diagnostics assays for histoplasmosis in people living with HIV.

    Article  Google Scholar 

  5. • Nacher M, Blanchet D, Bongomin F, Chakrabarti A, Couppié P, Demar M, et al. Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: a systematic review of diagnostic accuracy studies. PLoS neglected tropical diseases. 2018;12(10):e0006802. https://doi.org/10.1371/journal.pntd.0006802Systematic review onHistoplasmaantigen testing performance.

    Article  PubMed  PubMed Central  Google Scholar 

  6. •• WHO. Second WHO Model List of Essential In Vitro Diagnostics 2019 [Available from: https://www.who.int/medical_devices/publications/Standalone_document_v8.pdf?ua=1. World Health Organization second model list of essential in vitro diagnostics.

  7. • Mathieu N, Antoine A. Proceedings of First Histoplasmosis in the Americas and the Caribbean Meeting, Paramaribo, Suriname, December 4–6, 2015. Emerging Infectious Disease journal. 2016;22(9). https://doi.org/10.3201/eid2209.160408Summary of the first histoplasmosis in the Americas meeting.

Download references

Acknowledgments

We want to thank all the International Histoplasmosis Advocacy Group (iHAG) members: https://docs.google.com/spreadsheets/d/189W6gMfVb2zW5StAW2U2AbwVwGhls8bkAc7npZgNdC8/edit?ts=5d6d4758#gid=474498568. We also want to thank Eduardo Serrão for the meeting logistics and Pooja Gandhi for editing the manuscript. iHAG 2019 co-sponsors: Fundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD), Instituto Nacional de Pesquisas da Amazôna (INPA), Global Action Fund for Fungal Infections (GAFFI), International Society for Human and Animal Mycology (ISHAM), Mycoses Study Group Education and Research Consortium (MSGERC), Centre d'Investigation Clinique INSERM, Centre Hospitalier de Cayenne, Universidad del Rosario, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), and Santa Casa de Misericórdia de Porto Alegre.

Author information

Authors and Affiliations

  1. Centers for Disease Control and Prevention, Mycotic Diseases Branch, Mailstop H24-9, 1600 Clifton Rd, Atlanta, GA, 30333, USA

    Diego H. Caceres & Tom Chiller

  2. Centre d’Investigation Clinique Antilles Guyane, Inserm CIC1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana

    Antoine Adenis

  3. Instituto Nacional de Pesquisas da Amazônia, Coordenação de Sociedade, ambiente e saúde, Laboratório de Micologia, Manaus, Amazonas, AM 69060-001, Brazil

    João Vicente Braga de Souza & Mathieu Nacher

  4. Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, 11011, Colombia

    Beatriz L. Gomez

  5. Medical Mycology Laboratory, Tropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus, Amazonas, AM 69060-001, Brazil

    Katia Santana Cruz

  6. Universidade Federal de Ciências da Saúde Porto Alegre, and Santa Casa de misericórdia de Porto Alegre, Porto Alegre, RS, Brazil

    Alessandro C. Pasqualotto

  7. HIV, Hepatitis, Tuberculosis and STI Unit, Pan American Health Organization, D, Washington, .C, USA

    Giovanni Ravasi & Freddy Perez

  8. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil

    Marcus Vinicius Guimarares de Lacerda

  9. Fundação Oswaldo Cruz, Instituto Leônidas e Maria Deane (FIOCRUZ-Amazonas), Manaus, Amazonas, Brazil

    Marcus Vinicius Guimarares de Lacerda

Authors
  1. Diego H. Caceres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antoine Adenis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. João Vicente Braga de Souza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Beatriz L. Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katia Santana Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessandro C. Pasqualotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovanni Ravasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Freddy Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tom Chiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Marcus Vinicius Guimarares de Lacerda
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mathieu Nacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The International Histoplasmosis Advocacy Group (iHAG)

Corresponding author

Correspondence to Diego H. Caceres.

Ethics declarations

Conflict of Interest

The findings and the conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Epidemiology of Fungal Infections

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Caceres, D.H., Adenis, A., de Souza, J.V.B. et al. The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group. Curr Fungal Infect Rep 13, 244–249 (2019). https://doi.org/10.1007/s12281-019-00365-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-019-00365-3

Keywords

Search

Navigation